Skip to main content
. 2016 Apr 9;7(20):29102–29115. doi: 10.18632/oncotarget.8667

Table 1. Combination of carfilzomib with vorinostat induced G2-M arrest.

Cell cycle Control CFZ VOR CFZ and VOR
MOLT-4
G0G1 44.9 + 3.1 22.8 + 1.7 44.8 + 2.7 35.8 + 3.1
G2-M 12.3 + 1.5 20.2 + 2.1** 6.8 + 1.7 35.3 + 3.6
S 42.7 + 2.6 57.1 + 3.1 48.3 + 2.3 29.0 + 4.9
HuT 78
G0G1 54.3 + 2.7 44.2 + 1.7 54.0 + 2.7 41.2 + 1.6
G2-M 10.1 + 1.4 16.7 + 1.3** 6.3 + 1.2 38.0 + 2.6
S 35.6 + 3.7 39.2 + 0.7 39.7 + 3.6 20.8 + 1.0
**

represent significant differences relative to controls (p < 0.01);

represent significant differences relative to CFZ (p < 0.001).

CFZ, carfilzomib; VOR, vorinostat.